低密度脂蛋白胆固醇与胰岛素分泌相关
本研究纳入3039例未接受降胆固醇治疗但糖尿病风险增高的个体,行5点口服葡萄糖耐量试验。发现LDL胆固醇与C肽基胰岛素分泌指数正相关,与胰岛素基分泌指数负相关,且与胰岛素清除正相关;提示较低LDL胆固醇对应较低胰岛素分泌,可能解释降脂药致血糖控制恶化。
要点
- LDL胆固醇与C肽基胰岛素分泌指数正相关,提示较低LDL胆固醇者胰岛素分泌较低
- LDL胆固醇与胰岛素清除正相关,空腹及糖负荷后均显著
- LDL胆固醇与胰高血糖素水平无显著关联
核心结论
- C肽基指数反映不依赖肝清除的胰岛素分泌,结果提示较低LDL胆固醇时胰岛素分泌较低,可能解释降脂药致血糖控制恶化。
研究设计与样本
- 研究纳入3039例未接受降胆固醇治疗但糖尿病风险增高的个体,行常规血液检查及5点口服葡萄糖耐量试验。
主要发现
- LDL胆固醇与空腹胰高血糖素无关(P = .7,β = -.01),与糖负荷后胰高血糖素无关(P = .7,β = -.07)。
- LDL胆固醇与C肽基胰岛素分泌指数正相关:AUC C-Peptide(0-30min)/AUC Glucose(0-30min) P < .001,β = .06;AUC C-Peptide(0-120min)/AUC Glucose(0-120min) P < .001,β = -.08。
- LDL胆固醇与胰岛素基胰岛素分泌指数负相关:胰岛素生成指数 P = .01,β = -.04;处置指数 P < .001,β = -.06。
- LDL胆固醇与胰岛素清除正相关:空腹 P < .001,β = .09;糖负荷后 P < .001,β = .06。
临床怎么用
- 内分泌科医生解读血脂与糖代谢关系时,需注意LDL胆固醇较低可能伴随胰岛素分泌减少,降脂治疗中应监测血糖变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Pharmacological lowering of low-density lipoprotein (LDL) cholesterol potently reduces cardiovascular risk while concurrently increasing type 2 diabetes risk. OBJECTIVE: The aim of this study was to investigate the relationship between LDL cholesterol concentrations and insulin secretion and glucagon levels. METHODS: A total of 3039 individuals without cholesterol-lowering therapy, but with increased risk for diabetes, underwent routine blood tests and a 5-point oral glucose tolerance test (OGTT). Glucagon concentrations, insulin secretion, and insulin clearance indices were derived from the OGTT. RESULTS: There was no association between LDL cholesterol and fasting glucagon (P = .7, β = -.01) or post-glucose load glucagon levels (P = .7, β = -.07), but we detected significant positive associations of LDL cholesterol and C-peptide-based indices of insulin secretion (area under the curve [AUC]C-Peptide(0-30min)/AUCGlucose(0-30min): P < .001, β = .06; AUCC-Peptide(0-120min) /AUCGlucose(0-120min): P < .001, β = -.08). In contrast, we found a negative association of insulin-based insulin secretion indices with LDL concentrations (insulinogenic index: P = .01, β = -.04; disposition index: P < .001, β = -.06). LDL cholesterol levels, however, were positively associated with insulin clearance assessed from C-peptide and insulin concentrations, both in the fasting state and post-glucose load (P < .001, β = .09 and P < .001, β = .06, respectively). CONCLUSION: As C-peptide based indices reflect insulin secretion independent of hepatic clearance, our results indicate lower insulin secretion in case of lesser LDL cholesterol. This could explain deteriorating glycemic control in response to cholesterol-lowering drugs.
引用
- Dannecker C, Wagner R, Peter A, et al. Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion. J Clin Endocrinol Metab. 2021. PMID: 33693827. doi:10.1210/clinem/dgab147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。